Meet the Team Shaping the Future of Brain Health
Executive team
Dr. Julia Cooney
Medical doctor with a master's in biotechnology from Cambridge, Julia is a second time HealthTech founder with 10 years experience working across the clinical and commercial sides of healthcare. Despite starting her career on track to become a surgeon, Julia pivoted into HealthTech after her time at Cambridge, and now and serves as a medical advisor on several prominent boards. Her unique expertise straddles tech and medicine, making her well positioned to bring PREMAZ from the research lab into the hands of patients.
Cameron Kirkpatrick
Cameron has a background in biological sciences and a career spanning B2B and B2C SaaS across healthtech, finance, and enterprise software. As Co-Founder, he leads the company’s commercial strategy, with responsibility for clinical partnerships, sales, and pipeline growth.
He focuses on scaling the company’s commercial engine, building strategic partnerships, and translating market demand into sustainable, long-term growth.
Board of directors
Dr. Julia Cooney
Dr Julia Cooney is a medical doctor and second-time HealthTech founder. She has built and led ventures at the intersection of medicine and technology, with a focus on translating cutting-edge research into scalable healthcare solutions. As a Board Director, she contributes to company strategy, clinical governance, and the development of Prema Cognition as a category-defining platform in early cognitive health.
Cameron Kirkpatrick
Cameron has a background in biological sciences and extensive experience across B2B and B2C SaaS, spanning healthtech, finance, and enterprise software. He brings a strong track record in driving growth, commercial strategy, and strategic partnerships. As Chairman of the Board, Cameron supports the company’s long-term direction, working closely with the leadership team to scale operations, expand market reach, and build high-impact partnerships.
Jasbir Singh
Seasoned technology entrepreneur with over 35 years of experience founding, scaling, and exiting enterprise software companies across the BFSI and life sciences sectors. He brings deep expertise in software architecture, security, identity, compliance, and AI/ML, alongside a strong track record of guiding companies through growth and successful exits.
As a Non-Executive Director, Jasbir provides strategic oversight across technology, partnerships, and long-term positioning. He supports the company’s capital strategy and non-dilutive funding efforts, while advising on large-scale partnerships and exit pathways. He also oversees software architecture, regulatory, and compliance considerations across the tech team.
Strategic advisory
Stephen Hartman
Former General Counsel and Head of Corporate Development at Clarivate, a NYSE-listed global leader in innovation and intellectual property solutions. Brings deep expertise across governance, compliance, IP strategy, and M&A. As a Strategic Advisor, Steve provides guidance on board governance, regulatory frameworks (including GDPR and HIPAA), and corporate structuring for institutional scale. He also advises on IP protection, enterprise contracting, and strategic transactions, including partnerships and exit pathways.
Keith Williams
Biotech entrepreneur and technology leader with 30 years' experience in large-scale bioprocessing, pharma, SaaS, and synthetic biology. He has founded, scaled, and exited multiple companies, and brings deep expertise in project delivery, regulatory environments, and commercial strategy. At PREMAZ, Keith advises on regulatory pathways, CRO and pharma market strategy, and scaling the platform for rapid adoption.
Dr. Ravi Badge
Dr Ravi Badge is an NHS Consultant Orthopaedic Surgeon with extensive experience in sports medicine. He has a particular interest in sports-related traumatic brain injury (TBI) and leads clinical partnerships for PREMAZ in this area. Passionate about preventative healthcare, he is focused on advancing early screening tools for cognitive decline. Dr Badge has supported international athletes at major sporting events and contributes to ongoing research in sports-related brain health and injury prevention.
Scientific advisory
Dr Alan Thornhill
Dr Thornhill is a highly experienced and published expert in clinical genetics and diagnostics, with over 25 years spanning research, laboratory leadership, and biotechnology. He is currently Chief Scientific Officer at Advance Tests, an Alzheimer’s blood biomarker testing company focused on early detection of cognitive decline. As a Scientific Advisor to PREMAZ, Dr Thornhill provides guidance on biomarker strategy, clinical validation, and the integration of blood-based diagnostics with digital cognitive assessment to enable earlier and more precise detection of dementia.
Prof. Jon Simons
Professor of cognitive neuroscience at the University of Cambridge and a leading expert in cognitive health and memory research, with extensive academic leadership and a strong record of scientific publications.
Dr. Helena Gellersen
Dr Gellersen is a cognitive neuroscientist specializing in memory, ageing, and early neurodegenerative disease. Her research focuses on detecting the earliest cognitive changes using precision memory testing, neuroimaging, and digital assessment technologies. Dr Gellersen led the research into the precision memory work done at the Cambridge Memory Lab, and now serves as Scientific Lead at Prema Cognition, working to bring her work into the hands of patients.
Join our early adopter pilot program
And shape the future of brain health.
